Related Experiment Video
Updated: May 7, 2026

07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
STAT transcription in the ischemic heart
Richard A Knight1, Tiziano M Scarabelli, Anastasis Stephanou
1Medical Molecular Biology Unit; University College London; London, UK.
JAK-STAT
|September 24, 2013
Summary
Signal transducer and activator of transcription (STAT) proteins play dual roles in heart health. STAT1 promotes cell death, while STAT3 offers protection against ischemia but contributes to heart failure progression.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Physiology
Background:
- All seven STAT proteins are expressed in the heart.
- STAT proteins are crucial in cardiac physiology and disease.
- Their roles in ischemic heart disease are complex and multifaceted.
Purpose of the Study:
- To review the contribution of STAT proteins to cardiac physiology.
- To elucidate the roles of STAT1 and STAT3 in ischemic heart disease and its consequences.
- To understand the dualistic function of STAT proteins in cardiac myocytes.
Main Methods:
- Review of existing literature on STAT proteins in cardiac function and disease.
- Analysis of studies focusing on STAT1 and STAT3 in acute and chronic ischemic conditions.
- Examination of evidence from STAT3-deficient mouse models and cardioprotective agent studies.
Main Results:
- STAT1 exacerbates cardiac myocyte loss via apoptosis and reduced autophagy.
- STAT3 demonstrates cardioprotective effects in acute ischemia and is vital for preconditioning.
- Prolonged STAT3 activation, potentially with STAT5, promotes adverse post-infarction remodeling and heart failure.
Conclusions:
- STAT proteins, particularly STAT1 and STAT3, exhibit opposing roles in the acute phase of ischemic heart disease.
- STAT3 is essential for cardioprotection but implicated in the progression to heart failure.
- Understanding these STAT protein dynamics is key for developing therapeutic strategies for ischemic heart disease.
Related Concept Videos
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

